ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,000 | 0.0% | 1,052 | -43.0% | 0.00% | – |
| Q3 2020 | $1,000 | -98.0% | 1,846 | -97.4% | 0.00% | – |
| Q2 2020 | $51,000 | +292.3% | 69,718 | +405.9% | 0.00% | – |
| Q1 2020 | $13,000 | -95.7% | 13,782 | -90.8% | 0.00% | – |
| Q4 2019 | $304,000 | +186.8% | 149,337 | +306.5% | 0.00% | – |
| Q3 2019 | $106,000 | -90.1% | 36,738 | -73.6% | 0.00% | – |
| Q2 2019 | $1,069,000 | -62.2% | 139,369 | -34.5% | 0.00% | – |
| Q1 2019 | $2,829,000 | -74.4% | 212,937 | -69.9% | 0.00% | -100.0% |
| Q4 2018 | $11,031,000 | -17.1% | 707,997 | +4.5% | 0.00% | 0.0% |
| Q3 2018 | $13,309,000 | +402.8% | 677,362 | +634.5% | 0.00% | – |
| Q2 2018 | $2,647,000 | +100.5% | 92,222 | +65.2% | 0.00% | – |
| Q1 2018 | $1,320,000 | -5.0% | 55,809 | -13.9% | 0.00% | – |
| Q4 2017 | $1,390,000 | -70.3% | 64,789 | -67.3% | 0.00% | -100.0% |
| Q3 2017 | $4,679,000 | -3.0% | 197,840 | -19.2% | 0.00% | 0.0% |
| Q2 2017 | $4,825,000 | +12.3% | 244,945 | +19.7% | 0.00% | 0.0% |
| Q1 2017 | $4,298,000 | +54.3% | 204,672 | +38.2% | 0.00% | 0.0% |
| Q4 2016 | $2,785,000 | -20.2% | 148,102 | -11.3% | 0.00% | 0.0% |
| Q3 2016 | $3,488,000 | -40.9% | 167,042 | -27.8% | 0.00% | 0.0% |
| Q2 2016 | $5,903,000 | +27.2% | 231,444 | +32.0% | 0.00% | 0.0% |
| Q1 2016 | $4,639,000 | -31.8% | 175,392 | +10.3% | 0.00% | -50.0% |
| Q4 2015 | $6,805,000 | -4.2% | 159,052 | -40.6% | 0.00% | 0.0% |
| Q3 2015 | $7,101,000 | -7.8% | 267,818 | +15.9% | 0.00% | -33.3% |
| Q2 2015 | $7,704,000 | +27.4% | 231,152 | +27.2% | 0.00% | +50.0% |
| Q1 2015 | $6,045,000 | -28.1% | 181,657 | -11.7% | 0.00% | -33.3% |
| Q4 2014 | $8,408,000 | +20.2% | 205,740 | -0.3% | 0.00% | +50.0% |
| Q3 2014 | $6,995,000 | +3.0% | 206,458 | +2.5% | 0.00% | 0.0% |
| Q2 2014 | $6,789,000 | -19.0% | 201,403 | -8.9% | 0.00% | -33.3% |
| Q1 2014 | $8,381,000 | +14.0% | 221,066 | -12.2% | 0.00% | 0.0% |
| Q4 2013 | $7,352,000 | -8.9% | 251,774 | +6.7% | 0.00% | 0.0% |
| Q3 2013 | $8,070,000 | -2.6% | 235,966 | -6.0% | 0.00% | 0.0% |
| Q2 2013 | $8,285,000 | – | 251,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|